Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 713

1.

A Novel Non-invasive Method for Predicting Liver Fibrosis by Quantifying the Hepatic Vein Waveform.

Soroida Y, Nakatsuka T, Sato M, Nakagawa H, Tanaka M, Yamauchi N, Wake T, Nakagomi R, Kinoshita MN, Minami T, Uchino K, Enooku K, Asaoka Y, Tanaka Y, Endo M, Nakamura A, Kobayashi T, Kurihara M, Hikita H, Sato M, Gotoh H, Iwai T, Fukayama M, Ikeda H, Tateishi R, Yatomi Y, Koike K.

Ultrasound Med Biol. 2019 Jul 5. pii: S0301-5629(19)30238-8. doi: 10.1016/j.ultrasmedbio.2019.05.028. [Epub ahead of print]

PMID:
31303401
2.

MUC21 is a Key Molecule Involved in the Incohesive Growth Pattern in Lung Adenocarcinoma.

Yoshimoto T, Matsubara D, Soda M, Ueno T, Amano Y, Kihara A, Sakatani T, Nakano T, Shibano T, Endo S, Hagiwara K, Fukayama M, Denda-Nagai K, Irimura T, Mano H, Niki T.

Cancer Sci. 2019 Jul 13. doi: 10.1111/cas.14129. [Epub ahead of print]

PMID:
31301084
Free Article
3.

Rapid temporal improvement of pembrolizumab-induced pneumonitis using the anti-TNF-α antibody infliximab.

Sawai Y, Katsuya Y, Shinozaki-Ushiku A, Iwasaki A, Fukayama M, Watanabe K, Nagase T.

Drug Discov Ther. 2019 Jun 28. doi: 10.5582/ddt.2019.01032. [Epub ahead of print]

4.

Capturing the differences between humoral immunity in the normal and tumor environments from repertoire-seq of B-cell receptors using supervised machine learning.

Konishi H, Komura D, Katoh H, Atsumi S, Koda H, Yamamoto A, Seto Y, Fukayama M, Yamaguchi R, Imoto S, Ishikawa S.

BMC Bioinformatics. 2019 May 28;20(1):267. doi: 10.1186/s12859-019-2853-y.

5.

Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion.

Makise N, Sekimizu M, Kobayashi E, Yoshida H, Fukayama M, Kato T, Kawai A, Ichikawa H, Yoshida A.

Virchows Arch. 2019 May 17. doi: 10.1007/s00428-019-02588-8. [Epub ahead of print]

PMID:
31101969
6.

CADM1 associates with Hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis.

Ito T, Nakamura A, Tanaka I, Tsuboi Y, Morikawa T, Nakajima J, Takai D, Fukayama M, Sekido Y, Niki T, Matsubara D, Murakami Y.

Cancer Sci. 2019 Jul;110(7):2284-2295. doi: 10.1111/cas.14040. Epub 2019 May 29.

7.

Obstruction is associated with perineural invasion in T3/T4 colon cancer.

Nozawa H, Morikawa T, Kawai K, Hata K, Tanaka T, Nishikawa T, Sasaki K, Shuno Y, Kaneko M, Hiyoshi M, Emoto S, Murono K, Sonoda H, Fukayama M, Ishihara S.

Colorectal Dis. 2019 Apr 24. doi: 10.1111/codi.14655. [Epub ahead of print]

PMID:
31017742
8.

The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion.

Niikura R, Hayakawa Y, Hirata Y, Ogura K, Fujishiro M, Yamada A, Ushiku T, Konishi M, Fukayama M, Koike K.

Int J Mol Sci. 2019 Apr 18;20(8). pii: E1913. doi: 10.3390/ijms20081913.

9.

LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.

Nagata H, Ishihara S, Abe H, Ushiku T, Kishikawa J, Tanaka T, Hata K, Kawai K, Fukayama M, Nozawa H.

Br J Cancer. 2019 May;120(10):996-1002. doi: 10.1038/s41416-019-0442-5. Epub 2019 Apr 19.

PMID:
31000786
10.

c-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling.

Taguchi L, Miyakuni K, Morishita Y, Morikawa T, Fukayama M, Miyazono K, Ehata S.

Cancer Sci. 2019 Jun;110(6):2063-2074. doi: 10.1111/cas.14018. Epub 2019 May 3.

11.

Targeted antibody and cytokine cancer immunotherapies through collagen affinity.

Ishihara J, Ishihara A, Sasaki K, Lee SS, Williford JM, Yasui M, Abe H, Potin L, Hosseinchi P, Fukunaga K, Raczy MM, Gray LT, Mansurov A, Katsumata K, Fukayama M, Kron SJ, Swartz MA, Hubbell JA.

Sci Transl Med. 2019 Apr 10;11(487). pii: eaau3259. doi: 10.1126/scitranslmed.aau3259.

PMID:
30971453
12.

A comparison between 2- and 3-dimensional approaches to solid component measurement as radiological criteria for sublobar resection in lung adenocarcinoma ≤ 2 cm in size.

Yoshida Y, Manaka T, Nitadori JI, Shinozaki-Ushiku A, Doke T, Saito T, Sato J, Miyaji T, Yamaguchi T, Oyama H, Fukayama M, Nakajima Y, Nakajima J.

Surg Today. 2019 Apr 9. doi: 10.1007/s00595-019-01806-9. [Epub ahead of print]

PMID:
30968225
13.

Red Fluorescence Probe Targeted to Dipeptidylpeptidase-IV for Highly Sensitive Detection of Esophageal Cancer.

Ogasawara A, Kamiya M, Sakamoto K, Kuriki Y, Fujita K, Komatsu T, Ueno T, Hanaoka K, Onoyama H, Abe H, Tsuji Y, Fujishiro M, Koike K, Fukayama M, Seto Y, Urano Y.

Bioconjug Chem. 2019 Apr 17;30(4):1055-1060. doi: 10.1021/acs.bioconjchem.9b00198. Epub 2019 Apr 3.

PMID:
30920803
14.

Molecular analysis and literature-based hypothesis of an immunonegative prostate small cell carcinoma causing ectopic ACTH syndrome.

Takeuchi M, Sato J, Manaka K, Tanaka M, Matsui H, Sato Y, Kume H, Fukayama M, Iiri T, Nangaku M, Makita N.

Endocr J. 2019 Jun 28;66(6):547-554. doi: 10.1507/endocrj.EJ18-0563. Epub 2019 Mar 28.

15.

Keratinocyte Proline-Rich Protein Deficiency in Atopic Dermatitis Leads to Barrier Disruption.

Suga H, Oka T, Sugaya M, Sato Y, Ishii T, Nishida H, Ishikawa S, Fukayama M, Sato S.

J Invest Dermatol. 2019 Mar 21. pii: S0022-202X(19)31335-1. doi: 10.1016/j.jid.2019.02.030. [Epub ahead of print]

16.

Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.

Akiyama Y, Maeda D, Katoh H, Morikawa T, Niimi A, Nomiya A, Sato Y, Kawai T, Goto A, Fujimura T, Fukuhara H, Nakagawa T, Igawa Y, Ishikawa S, Fukayama M, Kume H, Homma Y.

J Urol. 2019 Aug;202(2):290-300. doi: 10.1097/JU.0000000000000234. Epub 2019 Jul 8.

PMID:
30865573
17.

Analysis of predictive factors for R0 resection and immediate bleeding of cold snare polypectomy in colonoscopy.

Aoki T, Yoshida S, Abe H, Ono S, Nakada A, Ota Y, Narita A, Yoshikawa T, Kinoshita H, Tsuji Y, Yamada A, Fujishiro M, Hirata Y, Fukayama M, Koike K.

PLoS One. 2019 Mar 1;14(3):e0213281. doi: 10.1371/journal.pone.0213281. eCollection 2019.

18.

Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism.

Sasako T, Ohsugi M, Kubota N, Itoh S, Okazaki Y, Terai A, Kubota T, Yamashita S, Nakatsukasa K, Kamura T, Iwayama K, Tokuyama K, Kiyonari H, Furuta Y, Shibahara J, Fukayama M, Enooku K, Okushin K, Tsutsumi T, Tateishi R, Tobe K, Asahara H, Koike K, Kadowaki T, Ueki K.

Nat Commun. 2019 Feb 27;10(1):947. doi: 10.1038/s41467-019-08591-6.

19.

Loss of RUNX3 Immunoreactivity in Non-Neoplastic Rectal Mucosa May Predict the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.

Shinagawa T, Hata K, Morikawa T, Matsunaga K, Emoto S, Murono K, Kaneko M, Sasaki K, Nishikawa T, Tanaka T, Kawai K, Nozawa H, Fukayama M, Ishihara S.

Digestion. 2019 Feb 14:1-9. doi: 10.1159/000497272. [Epub ahead of print]

PMID:
30763934
20.

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.

Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5.

21.

Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.

Okamoto H, Yoshimatsu Y, Tomizawa T, Kunita A, Takayama R, Morikawa T, Komura D, Takahashi K, Oshima T, Sato M, Komai M, Podyma-Inoue KA, Uchida H, Hamada H, Fujiu K, Ishikawa S, Fukayama M, Fukuhara T, Watabe T.

Sci Rep. 2019 Feb 4;9(1):1281. doi: 10.1038/s41598-019-39018-3.

22.

Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.

Nakayama A, Abe H, Kunita A, Saito R, Kanda T, Yamashita H, Seto Y, Ishikawa S, Fukayama M.

PLoS One. 2019 Jan 29;14(1):e0211358. doi: 10.1371/journal.pone.0211358. eCollection 2019.

23.

Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study.

Hakozaki M, Ito S, Fujii T, Kiya Y, Udagawa H, Fukayama M, Fukusato T.

Pathol Int. 2019 Feb;69(2):110-116. doi: 10.1111/pin.12755. Epub 2019 Jan 23.

PMID:
30672653
24.

Gastrointestinal: Reappraisal of the usefulness of percutaneous transhepatic cholangioscopy for indeterminate distal biliary strictures.

Mizuno S, Nakai Y, Tanaka M, Ushiku T, Arita J, Hasegawa K, Fukayama M, Koike K.

J Gastroenterol Hepatol. 2019 Jun;34(6):961. doi: 10.1111/jgh.14588. Epub 2019 Jan 22. Review. No abstract available.

PMID:
30669178
25.

Estrogen dermatitis: Case report and examination of estrogen receptor-β in the skin.

Fukayama M, Asano Y, Shinozaki-Ushiku A, Sato S.

J Dermatol. 2019 Mar;46(3):263-266. doi: 10.1111/1346-8138.14750. Epub 2019 Jan 10.

PMID:
30628111
26.

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO).

Kinoshita Y, Takashi Y, Ito N, Ikegawa S, Mano H, Ushiku T, Fukayama M, Nangaku M, Fukumoto S.

Bone Rep. 2018 Dec 31;10:100192. doi: 10.1016/j.bonr.2018.100192. eCollection 2019 Jun.

27.

Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.

Rokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E, Hosoda F, Yachida S, Tsuji Y, Fujishiro M, Koike K, Totoki Y, Fukayama M, Shibata T.

J Pathol. 2019 Apr;247(4):494-504. doi: 10.1002/path.5208. Epub 2019 Jan 16.

PMID:
30474112
28.

BHLHA15-Positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.

Hayakawa Y, Tsuboi M, Asfaha S, Kinoshita H, Niikura R, Konishi M, Hata M, Oya Y, Kim W, Middelhoff M, Hikiba Y, Higashijima N, Ihara S, Ushiku T, Fukayama M, Tailor Y, Hirata Y, Guha C, Yan KS, Koike K, Wang TC.

Gastroenterology. 2019 Mar;156(4):1066-1081.e16. doi: 10.1053/j.gastro.2018.11.024. Epub 2018 Nov 15.

PMID:
30448068
29.

EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.

Tanaka M, Shibahara J, Ishikawa S, Ushiku T, Morikawa T, Shinozaki-Ushiku A, Hayashi A, Misumi K, Tanaka A, Katoh H, Sakuma K, Kokudo T, Inagaki Y, Arita J, Sakamoto Y, Hasegawa K, Fukayama M.

Virchows Arch. 2019 Jan;474(1):39-46. doi: 10.1007/s00428-018-2476-0. Epub 2018 Oct 23.

PMID:
30349952
30.

Pine-cone and villi patterns are endoscopic signs suggestive of ulcerative colitis-associated colorectal cancer and dysplasia.

Shinagawa T, Hata K, Morikawa T, Takiyama H, Emoto S, Murono K, Kaneko M, Sasaki K, Nishikawa T, Tanaka T, Kawai K, Fukayama M, Nozawa H.

Gastrointest Endosc. 2019 Mar;89(3):565-575.e3. doi: 10.1016/j.gie.2018.09.037. Epub 2018 Oct 13.

PMID:
30326231
31.

Japanese familial anetoderma: A report of two cases and review of the published work.

Fukayama M, Miyagaki T, Akamata K, Suzuki S, Tanaka M, Sato S.

J Dermatol. 2018 Dec;45(12):1459-1462. doi: 10.1111/1346-8138.14672. Epub 2018 Oct 15. Review.

PMID:
30320485
32.

H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.

Makise N, Sekimizu M, Konishi E, Motoi T, Kubo T, Ikoma H, Watanabe SI, Okuma T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Mod Pathol. 2019 Mar;32(3):435-445. doi: 10.1038/s41379-018-0140-5. Epub 2018 Oct 5.

PMID:
30291346
33.

Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.

Sato K, Kawazu M, Yamamoto Y, Ueno T, Kojima S, Nagae G, Abe H, Soda M, Oga T, Kohsaka S, Sai E, Yamashita Y, Iinuma H, Fukayama M, Aburatani H, Watanabe T, Mano H.

Clin Cancer Res. 2019 Jan 1;25(1):378-389. doi: 10.1158/1078-0432.CCR-18-1574. Epub 2018 Oct 2.

PMID:
30279230
34.

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.

Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.

Cancer Med. 2018 Oct;7(10):5145-5154. doi: 10.1002/cam4.1763. Epub 2018 Sep 21.

35.

High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma.

Karasaki T, Qiang G, Anraku M, Sun Y, Shinozaki-Ushiku A, Sato E, Kashiwabara K, Nagayama K, Nitadori JI, Sato M, Murakawa T, Kakimi K, Fukayama M, Nakajima J.

J Thorac Dis. 2018 Aug;10(8):4741-4750. doi: 10.21037/jtd.2018.07.45.

36.

Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.

Shiratori H, Kawai K, Hata K, Tanaka T, Nishikawa T, Sasaki K, Kaneko M, Murono K, Emoto S, Morikawa T, Fukayama M, Nozawa H.

Oncology. 2019;96(1):33-43. doi: 10.1159/000492493. Epub 2018 Sep 13.

PMID:
30212816
37.

Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation.

Nakatsuka T, Soroida Y, Nakagawa H, Shindo T, Sato M, Soma K, Nakagomi R, Kobayashi T, Endo M, Hikita H, Sato M, Gotoh H, Iwai T, Yasui M, Shinozaki-Ushiku A, Shiraga K, Asakai H, Hirata Y, Fukayama M, Ikeda H, Yatomi Y, Tateishi R, Inuzuka R, Koike K.

Hepatol Res. 2019 Mar;49(3):304-313. doi: 10.1111/hepr.13248. Epub 2018 Sep 27.

PMID:
30182424
38.

Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.

Kinoshita H, Hayakawa Y, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Ikenoue T, Ushiku T, Fukayama M, Hirata Y, Koike K.

J Pathol. 2019 Jan;247(1):35-47. doi: 10.1002/path.5163. Epub 2018 Nov 27.

PMID:
30168144
39.

Development and internal validation of a risk scoring system for gastrointestinal events requiring surgery in gastrointestinal lymphoma patients.

Aoki T, Yamada A, Takahashi M, Niikura R, Toyama K, Ushiku T, Kurokawa M, Momose T, Fukayama M, Koike K.

J Gastroenterol Hepatol. 2019 Apr;34(4):693-699. doi: 10.1111/jgh.14452. Epub 2018 Sep 19.

PMID:
30151937
40.

Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents.

Tainaka K, Murakami TC, Susaki EA, Shimizu C, Saito R, Takahashi K, Hayashi-Takagi A, Sekiya H, Arima Y, Nojima S, Ikemura M, Ushiku T, Shimizu Y, Murakami M, Tanaka KF, Iino M, Kasai H, Sasaoka T, Kobayashi K, Miyazono K, Morii E, Isa T, Fukayama M, Kakita A, Ueda HR.

Cell Rep. 2018 Aug 21;24(8):2196-2210.e9. doi: 10.1016/j.celrep.2018.07.056.

41.

The prognostic value of PD-L1 expression in upper tract urothelial carcinoma varies according to platelet count.

Miyama Y, Morikawa T, Miyakawa J, Koyama Y, Kawai T, Kume H, Fukayama M.

Cancer Med. 2018 Sep;7(9):4330-4338. doi: 10.1002/cam4.1686. Epub 2018 Jul 31.

42.

Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset.

Tanaka A, Ishikawa S, Ushiku T, Yamazawa S, Katoh H, Hayashi A, Kunita A, Fukayama M.

Oncotarget. 2018 Jun 29;9(50):29336-29350. doi: 10.18632/oncotarget.25464. eCollection 2018 Jun 29.

43.

Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.

Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M.

Haematologica. 2018 Nov;103(11):1815-1824. doi: 10.3324/haematol.2018.190728. Epub 2018 Jul 5.

44.

Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.

Nishioka Y, Shindoh J, Inagaki Y, Gonoi W, Mitsui J, Abe H, Yoshioka R, Yoshida S, Fukayama M, Tsuji S, Hashimoto M, Hasegawa K, Kokudo N.

Dig Dis. 2018;36(6):437-445. doi: 10.1159/000490411. Epub 2018 Jul 3.

PMID:
29969766
45.

MED12 is frequently mutated in ovarian and other adnexal leiomyomas.

Li Z, Maeda D, Kudo-Asabe Y, Tamura D, Nanjo H, Hayashi A, Ikemura M, Fukayama M, Goto A.

Hum Pathol. 2018 Nov;81:89-95. doi: 10.1016/j.humpath.2018.06.013. Epub 2018 Jun 23.

PMID:
29944972
46.

Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.

Fukayama M, Kunita A, Kaneda A.

Adv Exp Med Biol. 2018;1045:437-457. doi: 10.1007/978-981-10-7230-7_20. Review.

PMID:
29896679
47.

MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.

Kunita A, Morita S, Irisa TU, Goto A, Niki T, Takai D, Nakajima J, Fukayama M.

Sci Rep. 2018 Jun 11;8(1):8838. doi: 10.1038/s41598-018-27128-3.

48.

A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.

Saito K, Isayama H, Sakamoto Y, Nakai Y, Ishigaki K, Tanaka M, Watadani T, Arita J, Takahara N, Mizuno S, Kogure H, Ijichi H, Tateishi K, Tada M, Hasegawa K, Fukayama M, Kokudo N, Koike K.

Med Oncol. 2018 May 30;35(7):100. doi: 10.1007/s12032-018-1158-8.

PMID:
29846849
49.

Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.

Furuya G, Abe H, Shinozaki-Ushiku A, Yamashita A, Ihara S, Hirata Y, Chiba A, Fujioka Y, Kurokawa M, Koike K, Fukayama M.

Pathol Res Pract. 2018 Jul;214(7):1051-1055. doi: 10.1016/j.prp.2018.05.022. Epub 2018 May 22.

PMID:
29843925
50.

Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.

Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Tsutsumi T, Nakagomi R, Minami T, Sato M, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Fukayama M, Koike K.

J Gastroenterol. 2018 Dec;53(12):1261-1275. doi: 10.1007/s00535-018-1472-0. Epub 2018 May 10.

Supplemental Content

Loading ...
Support Center